News + Filings Transactions Holdings
|
FMR LLC
> RVNC
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Revance Therapeutics, Inc. | RVNC | 1,955,915 | 110,683 | 49,504,209,000 | -9,930,714,000 | $25,310.00 |
03/31/2023 | Revance Therapeutics, Inc. | RVNC | 1,845,232 | 96,242 | 59,434,923,000 | 59,387,700,000 | $32,210.00 |
09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,748,990 | 534,672 | 47,223,000 | 30,441,000 | $27.00 |
06/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,214,318 | -17,512 | 16,782,000 | -7,239,000 | $13.82 |
03/31/2022 | Revance Therapeutics, Inc. | RVNC | 1,231,830 | 51,645 | 24,021,000 | 4,760,000 | $19.50 |
12/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,180,185 | -1,510,971 | 19,261,000 | -55,715,000 | $16.32 |
09/30/2021 | Revance Therapeutics, Inc. | RVNC | 2,691,156 | -4,144 | 74,976,000 | -4,913,000 | $27.86 |
06/30/2021 | Revance Therapeutics, Inc. | RVNC | 2,695,300 | -81,400 | 79,889,000 | 2,280,000 | $29.64 |
03/31/2021 | Revance Therapeutics, Inc. | RVNC | 2,776,700 | -75,300 | 77,609,000 | -3,217,000 | $27.95 |
12/31/2020 | Revance Therapeutics, Inc. | RVNC | 2,852,000 | 2,850,100 | 80,826,000 | 80,778,000 | $28.34 |
09/30/2020 | Revance Therapeutics, Inc. | RVNC | 1,900 | -5,700 | 48,000 | -138,000 | $25.26 |
06/30/2020 | Revance Therapeutics, Inc. | RVNC | 7,600 | 0 | 186,000 | 74,000 | $24.47 |
03/31/2020 | Revance Therapeutics, Inc. | RVNC | 7,600 | -25 | 112,000 | -11,000 | $14.74 |
12/31/2019 | Revance Therapeutics, Inc. | RVNC | 7,625 | 7,600 | 123,000 | 122,675 | $16.13 |
09/30/2019 | Revance Therapeutics, Inc. | RVNC | 25 | -35,400 | 325 | -458,675 | $13.00 |
06/30/2019 | Revance Therapeutics, Inc. | RVNC | 35,425 | -28,900 | 459,000 | -554,000 | $12.96 |
03/31/2019 | Revance Therapeutics, Inc. | RVNC | 64,325 | -22,501 | 1,013,000 | -735,000 | $15.75 |
12/31/2018 | Revance Therapeutics, Inc. | RVNC | 86,826 | -263,204 | 1,748,000 | -6,951,000 | $20.13 |
09/30/2018 | Revance Therapeutics, Inc. | RVNC | 350,030 | 241,830 | 8,699,000 | 5,729,000 | $24.85 |
06/30/2018 | Revance Therapeutics, Inc. | RVNC | 108,200 | -137,436 | 2,970,000 | -4,596,000 | $27.45 |
03/31/2018 | Revance Therapeutics, Inc. | RVNC | 245,636 | 44,036 | 7,566,000 | 359,000 | $30.80 |
12/31/2017 | Revance Therapeutics, Inc. | RVNC | 201,600 | -47,600 | 7,207,000 | 342,000 | $35.75 |
09/30/2017 | Revance Therapeutics, Inc. | RVNC | 249,200 | -76,700 | 6,865,000 | 6,856,396 | $27.55 |
06/30/2017 | Revance Therapeutics, Inc. | RVNC | 325,900 | 9,000 | 8,604 | -6,583,396 | $0.03 |
03/31/2017 | Revance Therapeutics, Inc. | RVNC | 316,900 | 216,900 | 6,592,000 | 4,522,000 | $20.80 |
12/31/2016 | Revance Therapeutics, Inc. | RVNC | 100,000 | 100,000 | 2,070,000 | 2,070,000 | $20.70 |
09/30/2016 | Revance Therapeutics, Inc. | RVNC | 0 | -555,600 | 0 | -18,979,000 | |
03/31/2016 | Revance Therapeutics, Inc. | RVNC | 0 | -555,600 | 0 | -18,979,000 | |
12/31/2015 | Revance Therapeutics, Inc. | RVNC | 555,600 | 555,600 | 18,979,000 | 18,979,000 | $34.16 |
12/31/2014 | Revance Therapeutics, Inc. | RVNC | 0 | -1,029,800 | 0 | -19,906,000 | |
09/30/2014 | Revance Therapeutics, Inc. | RVNC | 1,029,800 | 26,100 | 19,906,000 | -14,220,000 | $19.33 |
06/30/2014 | Revance Therapeutics, Inc. | RVNC | 1,003,700 | 700,400 | 34,126,000 | 24,572,000 | $34.00 |
03/31/2014 | Revance Therapeutics, Inc. | RVNC | 303,300 | 303,300 | 9,554,000 | 9,554,000 | $31.50 |
<< Prev Next >> |
|